- The Medicines Co. v. Mylan, Inc.
- Teva Pharms. USA, Inc. v. Sandoz Inc.
- Par Pharm., Inc. v. Luitpold Pharms., Inc.
- Mylan Institutional LLC v. Aurobindo Pharma Ltd.
- Braintree Labs., Inc. v. Breckenridge Pharm., Inc.
- Summer 2017ANDA Litigation Settlements
- The Medicines Co. v. Mylan Inc.
- Alza Corp. v. Amneal Pharmaceuticals of New York, LLC
- Summer 2017ANDA Approvals
- Horizon Pharma Ireland Ltd. v. Actavis Laboratories, UT, Inc.
- Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc.
- The Future of Mall Maps: “You are Here” and a Lot More
- Summer 2017Who Has Privity in Negligent Administration Claims?
- June 19, 2017Punctuation can be Pivotal in Interpreting Text
- The Supreme Court Holds the Lanham Act’s Disparagement Clause Unconstitutional
- June 2017DAPL: Storm Clouds on the Horizon in Indian Country
- June 2017Diversity in the Workplace: Gender Diversity at Play
- The Changing State of Retail: Creating More Instagrammable Moments
- Smart Store: How the Internet of Things is Changing Retail
- May 11, 2017Arbitration Options Put Global Insurers In The Driver Seat
- May 2, 2017When is a Flood a “Flood”: East Coast Edition
- Spring 2017Should iWorry? The ACTEC Technology Commentary on MPRC 1.1
- Finding the Perfect Fit: Garment Sizing Technology
- Shire Development, LLC v. Watson Pharms., Inc.
- Acorda Therapeutics Inc. v. Roxane Labs., Inc.
- Recro Gainesville LLC v. Actavis Labs. FL, Inc.
- Sanofi v. Lupin Atlantis Holdings SA
- Purdue Pharma L.P., v. Mylan Pharms. Inc.
- Helsinn Healthcare S.A. v. Dr. Reddy's Labs., Ltd.
- Novartis Pharms. Corp. v. Breckenridge Pharm., Inc.
- In re copaxone consolidated cases
- Endo Pharma. Solutions Inc. v. Custopharm, Inc.
- Eli Lilly and Co. v. Teva Parenteral Medicines, Inc.
- AstraZeneca AB v. Aurobindo Pharma Ltd.
- California’s Supreme Court Holds Arbitration Clauses Cannot Waive Public Injunctive Relief
- Par Pharm., Inc. v. Luitpold Pharms., Inc.
- Impax Labs., Inc. v. Lannett Holdings Inc.
- Apotex Inc. v. Alcon Research, Ltd.
- Shire Development, LLC v. Mylan Pharms., Inc.
- Allergan, Inc. v. Teva Pharms. USA, Inc.
- Allergan, Inc. v. Sandoz, Inc.
- Merck Sharp & Dohme Corp. v. Amneal Pharms. LLC
- Reckitt Benckiser LLC v. Aurobindo Pharma Ltd.
- Cumberland Pharms. Inc. v. Mylan Institutional LLC
- Spring 2017ANDA Litigation Settlements
- Spring 2017New ANDA Cases
- Spring 2017Generic Launches
- Spring 2017ANDA Approvals
- April 13, 2017E-filing May Be Easy, But It’s Not That Easy
- Dynamic Pricing: Is “Surge” Pricing Coming to Retail?
